β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1. [electronic resource]
Producer: 20110419Description: 19-29 p. digitalISSN:- 1555-8576
- Adrenergic beta-2 Receptor Antagonists -- pharmacology
- Animals
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation
- Cyclic AMP Response Element-Binding Protein -- antagonists & inhibitors
- Cyclooxygenase 2 -- genetics
- Electrophoretic Mobility Shift Assay
- Enzyme-Linked Immunosorbent Assay
- Humans
- Matrix Metalloproteinase 2 -- genetics
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- NF-kappa B -- antagonists & inhibitors
- Neoplasm Invasiveness
- Pancreatic Neoplasms -- drug therapy
- Propanolamines -- pharmacology
- RNA, Messenger -- genetics
- Receptors, Adrenergic, beta -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factor AP-1 -- antagonists & inhibitors
- Vascular Endothelial Growth Factor A -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.